Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$1.06 USD
-0.04 (-3.21%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $1.07 +0.02 (1.42%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Iterum Therapeutics (ITRM) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.52 per share. This reflects a positive earnings surprise of 42.31%. Look out for ITRM's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 23.33%.
Earnings History
Price & Consensus
Zacks News for ITRM
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services